Neuroimmune disorders of the central nervous system in children in the molecular era

[1]  O. Ciccarelli,et al.  Myelin oligodendrocyte glycoprotein and aquaporin‐4 antibodies are highly specific in children with acquired demyelinating syndromes , 2018, Developmental medicine and child neurology.

[2]  O. Ciccarelli,et al.  Disease Course and Treatment Responses in Children With Relapsing Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease , 2018, JAMA neurology.

[3]  O. Ciccarelli,et al.  ‘Leukodystrophy‐like’ phenotype in children with myelin oligodendrocyte glycoprotein antibody‐associated disease , 2018, Developmental medicine and child neurology.

[4]  A. Vincent,et al.  Autoimmune neurological disorders-does the age matter? , 2018, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[5]  M. Braun,et al.  Therapeutic Plasma Exchange Use in Pediatric Neurologic Disorders at a Tertiary Care Center: A 10-Year Review , 2018, Journal of child neurology.

[6]  G. de Saint Basile,et al.  Hemophagocytic syndrome: primary forms and predisposing conditions. , 2017, Current opinion in immunology.

[7]  C. Ahn,et al.  Two case reports , 2017, Medicine.

[8]  H. Lassmann,et al.  Inflammatory demyelinating diseases of the central nervous system , 2017, Handbook of Clinical Neurology.

[9]  K. Rostásy,et al.  Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome , 2017, Neurology.

[10]  C. Boutet,et al.  Anti-N-methyl-d-aspartate receptor encephalitis after Herpes simplex virus-associated encephalitis: an emerging disease with diagnosis and therapeutic challenges , 2017, Infection.

[11]  O. Ciccarelli,et al.  Diagnostic algorithm for relapsing acquired demyelinating syndromes in children , 2017, Neurology.

[12]  K. Rostásy,et al.  Myelin oligodendrocyte glycoprotein antibodies: How clinically useful are they? , 2017, Current opinion in neurology.

[13]  R. Dale,et al.  Autoimmune encephalitis in children: clinical phenomenology, therapeutics, and emerging challenges , 2017, Current opinion in neurology.

[14]  A. Frigo,et al.  Herpes simplex virus‐induced anti‐N‐methyl‐d‐aspartate receptor encephalitis: a systematic literature review with analysis of 43 cases , 2017, Developmental medicine and child neurology.

[15]  C. Geis,et al.  Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of the Central Nervous System. , 2017, Physiological reviews.

[16]  H. Heinze,et al.  ADEM-like presentation, anti-MOG antibodies, and MS pathology: TWO case reports , 2017, Neurology: Neuroimmunology & Neuroinflammation.

[17]  K. Chu,et al.  Anti‐LGI1 encephalitis is associated with unique HLA subtypes , 2017, Annals of neurology.

[18]  D. Roelen,et al.  Anti‐LGI1 encephalitis is strongly associated with HLA‐DR7 and HLA‐DRB4 , 2017, Annals of neurology.

[19]  S. Conroy,et al.  Systematic Review of the Toxicity of Long-Course Oral Corticosteroids in Children , 2017, PloS one.

[20]  A. Traboulsee,et al.  Ocrelizumab versus Interferon Beta‐1a in Relapsing Multiple Sclerosis , 2017, The New England journal of medicine.

[21]  A. Vincent,et al.  Pediatric Autoimmune Epileptic Encephalopathies , 2017, Journal of child neurology.

[22]  B. Balint,et al.  B-cell populations discriminate between pediatric- and adult-onset multiple sclerosis , 2016, Neurology: Neuroimmunology & Neuroinflammation.

[23]  Y. Crow,et al.  Type I interferon–mediated monogenic autoinflammation: The type I interferonopathies, a conceptual overview , 2016, The Journal of experimental medicine.

[24]  P. Panegyres,et al.  Anti-N-methyl-D-aspartate receptor encephalitis with an imaging-invisible ovarian teratoma: a case report , 2016, Journal of Medical Case Reports.

[25]  S. T. Govindarajan,et al.  Neuroinflammatory component of gray matter pathology in multiple sclerosis , 2016, Annals of neurology.

[26]  A. Ponsonby,et al.  Environmental and genetic factors in pediatric inflammatory demyelinating diseases , 2016, Neurology.

[27]  A. Bar-Or,et al.  Immunopathophysiology of pediatric CNS inflammatory demyelinating diseases , 2016, Neurology.

[28]  S. Hantus,et al.  [F]-Fluoro-Deoxy-Glucose Positron Emission Tomography Scan Should Be Obtained Early in Cases of Autoimmune Encephalitis , 2016 .

[29]  Chao Lu,et al.  Retrospective study , 2016, Medicine.

[30]  F. Paul,et al.  Structural Hippocampal Damage Following Anti-N-Methyl-D-Aspartate Receptor Encephalitis , 2016, Biological Psychiatry.

[31]  P. Trillenberg,et al.  Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica , 2016, Journal of Neurology, Neurosurgery & Psychiatry.

[32]  Mamta B. Singh,et al.  Corticosteroids for managing tuberculous meningitis , 2016, The Cochrane database of systematic reviews.

[33]  R. Dale,et al.  Symptomatic treatment of children with anti‐NMDAR encephalitis , 2016, Developmental medicine and child neurology.

[34]  A. Venkatesan,et al.  A clinical approach to diagnosis of autoimmune encephalitis , 2016, The Lancet Neurology.

[35]  David H. Miller,et al.  Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trial , 2016, The Lancet Neurology.

[36]  A. Vincent,et al.  Paediatric brainstem encephalitis associated with glial and neuronal autoantibodies , 2016, Developmental medicine and child neurology.

[37]  C. Lucchinetti,et al.  Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin‐4 channelopathies: a decade later , 2016, Annals of the New York Academy of Sciences.

[38]  M. Nolan,et al.  Rituximab monitoring and redosing in pediatric neuromyelitis optica spectrum disorder , 2016, Neurology: Neuroimmunology & Neuroinflammation.

[39]  Anthony Traboulsee,et al.  Corticospinal tract integrity measured using transcranial magnetic stimulation and magnetic resonance imaging in neuromyelitis optica and multiple sclerosis , 2016, Multiple sclerosis.

[40]  C. Serguera,et al.  Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis , 2015, Journal of Neuroimmunology.

[41]  C. Ploner,et al.  Imaging of autoimmune encephalitis – Relevance for clinical practice and hippocampal function , 2015, Neuroscience.

[42]  K. Rostásy,et al.  Autoimmune post–herpes simplex encephalitis of adults and teenagers , 2015, Neurology.

[43]  A. Vincent,et al.  Clinical relevance of voltage-gated potassium channel–complex antibodies in children , 2015, Neurology.

[44]  T. Ørntoft,et al.  Functional IRF3 deficiency in a patient with herpes simplex encephalitis , 2015, The Journal of experimental medicine.

[45]  Y. Crow,et al.  Neuromyelitis optica in a child with Aicardi-GoutiÈres syndrome , 2015, Neurology.

[46]  A. Traboulsee,et al.  International consensus diagnostic criteria for neuromyelitis optica spectrum disorders , 2015, Neurology.

[47]  D. Reich,et al.  Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis , 2015, Neurology.

[48]  A. Ruíz-Patiño,et al.  Specificity and sensitivity of aquaporin 4 antibody detection tests in patients with neuromyelitis optica: A meta-analysis. , 2015, Multiple sclerosis and related disorders.

[49]  Y. Crow,et al.  Aicardi–Goutières syndrome and the type I interferonopathies , 2015, Nature Reviews Immunology.

[50]  Sean J Pittock,et al.  Autoimmune Epilepsy , 2015, Seminars in Neurology.

[51]  A. Vincent,et al.  Pediatric Herpes Simplex Virus Encephalitis Complicated by N-Methyl-D-aspartate Receptor Antibody Encephalitis. , 2015, Journal of the Pediatric Infectious Diseases Society.

[52]  J. Benito-León,et al.  Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease , 2015, Multiple sclerosis.

[53]  M. Dalakas,et al.  GAD65 epitope mapping and search for novel autoantibodies in GAD-associated neurological disorders , 2015, Journal of Neuroimmunology.

[54]  A. Vincent,et al.  Infectious and Autoantibody-Associated Encephalitis: Clinical Features and Long-term Outcome , 2015, Pediatrics.

[55]  K. Fujihara,et al.  MOG cell-based assay detects non-MS patients with inflammatory neurologic disease , 2015, Neurology: Neuroimmunology & Neuroinflammation.

[56]  F. Paul,et al.  MRI characteristics of neuromyelitis optica spectrum disorder , 2015, Neurology.

[57]  Jacqueline A Palace,et al.  Myelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in children , 2015, Neurology: Neuroimmunology & Neuroinflammation.

[58]  S. Latour,et al.  XIAP deficiency syndrome in humans. , 2015, Seminars in cell & developmental biology.

[59]  C. Catsman-Berrevoets,et al.  Anti-MOG antibodies plead against MS diagnosis in an Acquired Demyelinating Syndromes cohort , 2015, Multiple sclerosis.

[60]  A. Vanderver,et al.  DARS-associated leukoencephalopathy can mimic a steroid-responsive neuroinflammatory disorder , 2015, Neurology.

[61]  D. Arnold,et al.  Epitope spreading as an early pathogenic event in pediatric multiple sclerosis , 2014, Neurology.

[62]  A. Bar-Or,et al.  Multiple sclerosis in children: an update on clinical diagnosis, therapeutic strategies, and research , 2014, The Lancet Neurology.

[63]  K. Fujihara,et al.  Cerebrospinal Fluid Aquaporin-4 Antibody Levels in Neuromyelitis Optica Attacks , 2014, Annals of neurology.

[64]  B. Banwell,et al.  Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease , 2014, Neurology.

[65]  R. Balice-Gordon,et al.  Acute Mechanisms Underlying Antibody Effects in Anti–N-Methyl-D-Aspartate Receptor Encephalitis , 2014, Annals of neurology.

[66]  Kristy Brown,et al.  Aicardi–Goutières syndrome harbours abundant systemic and brain-reactive autoantibodies , 2014, Annals of the rheumatic diseases.

[67]  J. Dalmau,et al.  Autoimmune encephalitis as differential diagnosis of infectious encephalitis. , 2014, Current opinion in neurology.

[68]  D. Booth,et al.  Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton , 2014, Neurology: Neuroimmunology & Neuroinflammation.

[69]  A. Vincent,et al.  NMDA receptor antibodies associated with distinct white matter syndromes , 2014, Neurology: Neuroimmunology & Neuroinflammation.

[70]  S. Kusunoki,et al.  Efficacy of the anti–IL-6 receptor antibody tocilizumab in neuromyelitis optica , 2014, Neurology.

[71]  M. Dalakas.  Mechanistic Effects of IVIg in Neuroinflammatory Diseases: Conclusions Based on Clinicopathologic Correlations , 2014, Journal of Clinical Immunology.

[72]  M. Kuhn,et al.  The Effects of Dexamethasone and Acyclovir on a Cell Culture Model of Delayed Facial Palsy , 2014, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[73]  M. Papadopoulos,et al.  Neuromyelitis optica MOG-IgG causes reversible lesions in mouse brain , 2014, Acta neuropathologica communications.

[74]  A. Vanderver,et al.  Comprehensive Immunophenotyping of Cerebrospinal Fluid Cells in Patients with Neuroimmunological Diseases , 2014, The Journal of Immunology.

[75]  L. Lagae,et al.  Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling , 2014, Nature Genetics.

[76]  Huidy Shu,et al.  Overlapping demyelinating syndromes and anti–N‐methyl‐D‐aspartate receptor encephalitis , 2014, Annals of neurology.

[77]  R. Balice-Gordon,et al.  Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study , 2014, The Lancet Neurology.

[78]  F. Jensen,et al.  Rasmussen's encephalitis: clinical features, pathobiology, and treatment advances , 2014, The Lancet Neurology.

[79]  A. Vanderver,et al.  Therapies in Aicardi–Goutières syndrome , 2014, Clinical and experimental immunology.

[80]  A. Vincent,et al.  N‐methyl‐D‐aspartate receptor antibodies in post–herpes simplex virus encephalitis neurological relapse , 2014, Movement disorders : official journal of the Movement Disorder Society.

[81]  A. Vanderver,et al.  Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study , 2013, The Lancet Neurology.

[82]  J. Browning,et al.  Feasibility of the Use of Combinatorial Chemokine Arrays to Study Blood and CSF in Multiple Sclerosis , 2013, PloS one.

[83]  R. Bullock,et al.  Biomarkers for the Clinical Differential Diagnosis in Traumatic Brain Injury—A Systematic Review , 2013, CNS neuroscience & therapeutics.

[84]  S. Benseler,et al.  CNS vasculitis in children. , 2013, Multiple sclerosis and related disorders.

[85]  D. Streiner,et al.  Development of a Standardized MRI Scoring Tool for CNS Demyelination in Children , 2013, American Journal of Neuroradiology.

[86]  A. Ghezzi,et al.  International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions , 2013, Multiple sclerosis.

[87]  M. Papadopoulos,et al.  Aquaporin water channels in the nervous system , 2013, Nature Reviews Neuroscience.

[88]  L. Honig,et al.  Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study , 2013, The Lancet Neurology.

[89]  D. Cox,et al.  B cell exchange across the blood-brain barrier in multiple sclerosis. , 2012, The Journal of clinical investigation.

[90]  J. Dalmau,et al.  Paraneoplastic neurological syndromes. , 1988, Cancer Investigation.

[91]  P. Fallon,et al.  Paediatric autoimmune encephalopathies: clinical features, laboratory investigations and outcomes in patients with or without antibodies to known central nervous system autoantigens , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[92]  J. Dalmau,et al.  Persistent intrathecal antibody synthesis 15 years after recovering from anti-N-methyl-D-aspartate receptor encephalitis. , 2012, JAMA neurology.

[93]  John H Livingston,et al.  Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature , 2012, Nature Genetics.

[94]  E. Frechette,et al.  Extreme delta brush , 2012, Neurology.

[95]  B. Seitz,et al.  A randomized, double‐blind, phase 2 study of erythropoietin in optic neuritis , 2012, Annals of neurology.

[96]  Jacqueline Palace,et al.  Myasthenia gravis and neuromyelitis optica spectrum disorder , 2012, Neurology.

[97]  K. Jellinger,et al.  Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis. , 2012, Brain : a journal of neurology.

[98]  F. Georges,et al.  Disrupted surface cross-talk between NMDA and Ephrin-B2 receptors in anti-NMDA encephalitis. , 2012, Brain : a journal of neurology.

[99]  A. Bar-Or,et al.  Implication of perturbed axoglial apparatus in early pediatric multiple sclerosis , 2012, Annals of neurology.

[100]  J. Dalmau,et al.  The frequency of autoimmune N-methyl-D-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[101]  R. Goldbach-Mansky,et al.  Immunology in clinic review series; focus on autoinflammatory diseases: update on monogenic autoinflammatory diseases: the role of interleukin (IL)‐1 and an emerging role for cytokines beyond IL‐1 , 2012, Clinical and experimental immunology.

[102]  Jacqueline Palace,et al.  Serologic diagnosis of NMO , 2012, Neurology.

[103]  J. Casanova,et al.  Inborn errors of anti-viral interferon immunity in humans. , 2011, Current opinion in virology.

[104]  M. Swartz.  A decade later. , 2011, Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners.

[105]  Simon C. Potter,et al.  Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis , 2011, Nature.

[106]  E. Mowry,et al.  Common viruses associated with lower pediatric multiple sclerosis risk , 2011, Neurology.

[107]  Jeffrey A. Cohen,et al.  Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.

[108]  S. Benseler,et al.  Diagnosing central nervous system vasculitis in children , 2010, Current opinion in pediatrics.

[109]  D. Neilson.  The interplay of infection and genetics in acute necrotizing encephalopathy , 2010, Current opinion in pediatrics.

[110]  R. Dale,et al.  Biomarkers of inflammatory and auto-immune central nervous system disorders , 2010, Current opinion in pediatrics.

[111]  W. Halliday,et al.  Brain biopsy in children with primary small‐vessel central nervous system vasculitis , 2010, Annals of neurology.

[112]  Brigitte Wildemann,et al.  AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance , 2010, Nature Reviews Neurology.

[113]  G. Giovannoni,et al.  Multiple sclerosis: risk factors, prodromes, and potential causal pathways , 2010, The Lancet Neurology.

[114]  R. Cohrs,et al.  Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment , 2009, The Lancet Neurology.

[115]  M. Rosenfeld,et al.  Anti–N‐methyl‐D‐aspartate receptor (NMDAR) encephalitis in children and adolescents , 2009, Annals of neurology.

[116]  Jonathan C. Fuller,et al.  Mutations involved in Aicardi-Goutières syndrome implicate SAMHD1 as regulator of the innate immune response , 2009, Nature Genetics.

[117]  Jacqueline A Palace,et al.  Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis. , 2008, Archives of neurology.

[118]  F. Schmidt.  Meta-Analysis , 2008 .

[119]  P. Kennedy,et al.  The neurotropic herpes viruses: herpes simplex and varicella-zoster , 2007, The Lancet Neurology.

[120]  A. Bar-Or,et al.  Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study , 2007, The Lancet Neurology.

[121]  G. Krishnamoorthy,et al.  Spontaneous opticospinal encephalomyelitis in a double-transgenic mouse model of autoimmune T cell/B cell cooperation. , 2006, The Journal of clinical investigation.

[122]  C. Ponting,et al.  Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutières syndrome and mimic congenital viral brain infection , 2006, Nature Genetics.

[123]  D. Barnes,et al.  Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 cause Aicardi-Goutières syndrome at the AGS1 locus , 2006, Nature Genetics.

[124]  M. Burns,et al.  Case-Control Study , 2020, Definitions.

[125]  R. Tellier,et al.  Epstein-Barr virus in pediatric multiple sclerosis. , 2004, JAMA.

[126]  J. Blackman,et al.  Paroxysmal autonomic instability with dystonia after brain injury. , 2004, Archives of neurology.

[127]  D. Schiff,et al.  Anti-GAD Antibody Positive Stiff-Limb Syndrome in Multiple Myeloma , 2003, Journal of Neuro-Oncology.

[128]  E. Remmers,et al.  De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases. , 2002, Arthritis and rheumatism.

[129]  Jan Bauer,et al.  T‐ and B‐cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis , 2001, Glia.

[130]  C. Baird,et al.  The pilot study. , 2000, Orthopedic nursing.

[131]  L. Horton.  International Update , 1998, PS: Political Science & Politics.

[132]  H. Gnehm,et al.  Dexamethasone therapy for bacterial meningitis in children , 1993, The Lancet.

[133]  H. Moser,et al.  Childhood adrenoleukodystrophy. Failure of intensive immunosuppression to arrest neurologic progression. , 1988, Archives of neurology.

[134]  J. Routy,et al.  Clinical outcome after lipectomy in the management of patients with human immunodeficiency virus-associated dorsocervical fat accumulation , 2019, Medicine.

[135]  A. Vincent,et al.  Autoimmune encephalopathies. , 2015, Pediatric clinics of North America.

[136]  R. Balice-Gordon,et al.  Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice. , 2015, Brain : a journal of neurology.

[137]  Lucas G. Patrocinio,et al.  A 10-Year Review , 2015 .

[138]  T. Ørntoft,et al.  Functional IRF 3 deficiency in a patient with herpes simplex encephalitis , 2015 .

[139]  F. Barkhof,et al.  MRI mimics of multiple sclerosis. , 2014, Handbook of clinical neurology.

[140]  Huidy Shu,et al.  Overlapping demyelinating syndromes and anti-NMDA receptor encephalitis , 2014 .

[141]  E. Frechette,et al.  A unique EEG pattern in adults with anti-NMDA receptor encephalitis , 2012 .

[142]  D. C. Henckel,et al.  Case report. , 1995, Journal.

[143]  H. Gnehm,et al.  Dexamethasone therapy for bacterial meningitis in children. Swiss Meningitis Study Group. , 1993, Lancet.

[144]  F. Maccallum.  Herpes simplex and varicella-zoster. , 1959, The Practitioner.